Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Dendreon Corporation    

End-of-day quote. End-of-day quote  - 06/11
0.0325 USD   -4.41%
2015DJValeant Approved to Buy Dendreon Assets for $495 Million
2015 Drugmaker Valeant close to buying Salix - source
2015 VALEANT SECURES : Bloomberg
 SummaryChartsNewsCalendarCompanyFinancials 
Company
Dendreon Corp. is a biotechnology company, which focuses on discovery, development and commercialization of novel therapeutics that improves cancer treatment options for patients.The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular... 
More about the company
Latest news on DENDREON CORPORATION
2015 DENDREON : Regulation FD Disclosure, Change in Directors or Principal Officers (..
2015 DENDREON : Material Modification to Rights of Security Holders, Regulation FD Di..
2015 DENDREON : Regulation FD Disclosure (form 8-K)
2015 DENDREON : Regulation FD Disclosure, Other Events, Financial Statements and Exhi..
2015DJValeant Approved to Buy Dendreon Assets for $495 Million
2015 Drugmaker Valeant close to buying Salix - source
2015 VALEANT SECURES FINANCING FOR POTENT : Bloomberg
2015DJEnergy Future Fights for Control of its Bankruptcy -- Week Ahead
More news
Sector news : Biotechnology & Medical Research - NEC
04/29 SANOFI : offers to buy Medivation for $9.3bn
04/29 SANOFI : France's Sanofi makes $9.3 billion bid for US cancer drug giant
04/29DJSanofi Seeks Talks With Medivation Over $9.3 Billion Offer -- 2nd Update
More sector news : Biotechnology & Medical Research - NEC
Comments 
Advertisement
Chart DENDREON CORPORATION
Duration : Period :
Dendreon Corporation Technical Analysis Chart | US24823Q1076 | 4-Traders
Full-screen chart
Technical analysis trends DENDREON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials